Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and healthy Ageing (Action Plan B3: Area 5)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F16%3A10330055" target="_blank" >RIV/00669806:_____/16:10330055 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/16:10330055 RIV/61989592:15110/16:33159314
Result on the web
<a href="http://dx.doi.org/10.1186/s13601-016-0116-9" target="_blank" >http://dx.doi.org/10.1186/s13601-016-0116-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s13601-016-0116-9" target="_blank" >10.1186/s13601-016-0116-9</a>
Alternative languages
Result language
angličtina
Original language name
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and healthy Ageing (Action Plan B3: Area 5)
Original language description
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30225 - Allergy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical and Translational Allergy [online]
ISSN
2045-7022
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
July
Country of publishing house
GB - UNITED KINGDOM
Number of pages
18
Pages from-to
—
UT code for WoS article
000390119300001
EID of the result in the Scopus database
2-s2.0-85006427875